Efficacy and Safety of Botulinum Toxin A for Treating Bladder Hyperactivity in Children and Adolescents with Neuropathic Bladder Secondary to Myelomeningocele

<table>Multipoint injection scheme (1 cm<sup>3</sup> = 10 IU of BTX-A injected in 20 sites, sparing periureteral areas).</table>

Dataset Papers in Science

fig1

Figure 1

Figure 1: Efficacy and Safety of Botulinum Toxin A for Treating Bladder Hyperactivity in Children and Adolescents with Neuropathic Bladder Secondary to Myelomeningocele 

Figure 1 | Efficacy and Safety of Botulinum Toxin A for Treating Bladder Hyperactivity in Children and Adolescents with Neuropathic Bladder Secondary to Myelomeningocele 